Eventide Asset Management’s Avalyn Pharma AVLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$39.2M Hold
1,375,486
– – 0.55% 57
2026
Q2
$45.3M Buy
+1,375,486
New +$39.7M 0.61% 55

Other funds holding AVLN

Eventide Asset Management's AVLN Position: Q3 2026 in Review

Eventide Asset Management held its Avalyn Pharma (AVLN) position steady in Q3 2026 at 1,375,486 shares worth $39.2M. The position accounts for 0.55% of the portfolio, ranked #57.

Eventide Asset Management first reported a position in AVLN in Q2 2026 and has held it in 2 quarters since. The position peaked at $45.3M in Q2 2026. 61 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.

  • Eventide Asset Management held 1,375,486 shares of Avalyn Pharma worth $39.2M as of Q3 2026.
  • Eventide Asset Management left its Avalyn Pharma share count unchanged in Q3 2026.
  • Avalyn Pharma made up 0.55% of Eventide Asset Management's portfolio in Q3 2026, its #57 holding.
  • Eventide Asset Management first reported a position in Avalyn Pharma in Q2 2026 and has held it in 2 quarters since.
  • Eventide Asset Management's Avalyn Pharma position peaked at $45.3M in Q2 2026.
  • 61 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.

Based on Eventide Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.